GREG LARSEN: Open Payments
NPI 1578879441 · ST GEORGE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 43 payments from 16 companies in 2025. Trend: 2023 $849 · 2024 $1,011 · 2025 $810
Food & beverage: $810
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 7 | $198 |
| Amgen Inc. | 13 | $185 |
| ANI Pharmaceuticals, Inc. | 3 | $62 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
| Calliditas Therapeutics US Inc. | 3 | $52 |
| Novartis Pharmaceuticals Corporation | 3 | $47 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Mallinckrodt Hospital Products Inc. | 1 | $27 |
| Alexion Pharmaceuticals, Inc. | 1 | $25 |
| Apellis Pharmaceuticals, Inc. | 1 | $22 |
Products named: TAVNEOS, PURIFIED CORTROPHIN GEL, JYNARQUE, TARPEYO, KRYSTEXXA, BENLYSTA, ACTHAR, ULTOMIRIS.
Industry payments across UT — which companies pay providers there.
